NewsBite

BioNTech

Advertisement
Technicians at work in a BioNTech lab in Germany.

mRNA giant wants changes to vaccine regulations to speed up new jabs

BioNTech is one of the world’s two leading mRNA companies, and it has just announced it will open a research and development hub in Melbourne.

  • Liam Mannix

Latest

New vacccine will target Omicron.

Britain first to approve COVID-19 vaccine targeting Omicron variant

Britain has become the first country to authorise an updated coronavirus jab that directly targets the Omicron strain of the virus.

  • Rob Harris
Pfizer says tweaking its COVID-19 vaccine to better target the Omicron variant is safe and boosts protection.

Tweaked vaccines boost Omicron protection, Pfizer says

In a study of adults who’d already had three vaccine doses, Pfizer said two new booster methods substantially increased Omicron-fighting antibodies.

  • Lauran Neergaard
Heart transplant patient Moshe Geva Rosso receives a fourth dose of the COVID vaccine in Ramat Gan, Israel.

Fourth COVID vaccine shot found to be highly effective

Pfizer chief executive Albert Bourla meanwhile said an annual COVID-19 vaccine would be preferable to more regular booster shots.

  • Jeffrey Heller
A researcher prepares to sequence COVID-19 samples in South Africa this month.

Study indicates Omicron is milder, better at evading vaccines

A two-dose Pfizer vaccination appears to provide just 33 per cent protection against infection during South Africa’s current Omicron wave.

  • Andrew Meldrum
A child receives a vaccine against COVID-19 at a vaccination site on November 18, 2021 in Wuhan, China.

How COVID shots for kids help prevent dangerous new variants

The mass vaccination of children could make a real difference to preventing the future spread of the coronavirus, medical researchers say.

  • Laura Ungar
Advertisement
A nurse receives a Pfizer COVID-19 booster shot at a hospital in Miami this month.

Pfizer says COVID-19 booster shot showed high efficacy in large study

A booster dose of the COVID-19 vaccine restored efficacy to 95.6 per cent against the virus, including the Delta variant, data released by the company shows.

Pfizer and its German partner BioNTech said their research shows younger children should get one-third of the dose now given to everyone else.

Pfizer asks US to allow COVID vaccinations for children aged 5 to 11

Pfizer and its German partner BioNTech say their research shows that younger children should get one-third of the dose now given to everyone else.

  • Lauran Neergaard and Jennifer McDermott
All school students in California will need to be vaccinated against COVID-19 once the shots are federally approved for their age groups.

California to mandate COVID-19 vaccines for schoolchildren

Children attending school in California will need to be vaccinated against COVID-19 once the shots are federally approved for their age groups, the Governor announced.

  • Romy Varghese and David R. Baker
The WHO has argued that the vaccines are still needed for first doses around the globe.

COVID vaccine boosters not widely needed, top FDA and WHO scientists say

Additional COVID-19 vaccine booster shots are not needed for the general population, leading scientists said in an article published in the Lancet medical journal.

  • Ahmed Aboulenein

Original URL: https://www.watoday.com.au/topic/biontech-se-1npi